The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Eurozone GDP data lifts markets as resource stocks rise

Fri, 13th Feb 2015 11:37

Stronger-than-expected Eurozone growth figures and easing concerns about Ukraine and Greece gave stocks a boost in London on Friday, with resource shares leading the advance.The FTSE 100 was trading 0.6% higher at 6,869 by midday, as metal and oil stocks tracked commodity prices higher.Eurozone gross domestic product (GDP) growth picked up to 0.3% in the fourth quarter of 2014 from 0.2% in the third quarter, surprising analysts who had expected the rate of expansion to remain unchanged.German GDP came in particularly strong, expanding by 0.7% in the fourth quarter from 0.1% the preceding three months, well ahead of the 0.3% growth predicted in Europe's largest economy.The better-than-expected data will come as welcome news for the European Central Bank president Mario Draghi, who faced an uphill task in trying to steer the Eurozone out of deflation."Mario Draghi has bought himself a bit of time, as year-on-year figures show small signs of Eurozone growth following the significant bond buying programme he announced recently," Dennis de Jong, managing director at UFX.com.Concerns about the Ukraine crisis have also eased after the country agreed to a ceasefire with Russia after tense negotiations in Minsk. However, there was continued fighting overnight in the rebel-held cities of eastern Ukraine, with the ceasefire not expected to kick in until Sunday."Investors also appear confident that a Greek disaster can also be averted on unconfirmed reports that German and Greek officials were working on a compromise in Brussels as both sides looked to soften their positions," said analyst Michael Hewson from CMC Markets. The speculation comes before the next Eurogroup meeting scheduled to begin on Monday.Anglo leads miners higherThe share price of Anglo American advanced despite the news that it has decided to write-down the value of certain assets by $3.9bn on the back of weaker iron ore prices, pushing the company into the red for the 2014 financial year. Anglo swung to a pre-tax loss of $259m in 2014, compared with a profit of $1.7bn in 2013.Other miners were also in positive territory, including BHP Billiton, Glencore and Rio Tinto, as metal prices improved. Even Fresnillo gained despite explaining how foreign exchange movements, depreciation and write-downs would adversely affect its 2014 results.Oil stocks such as Tullow, BG and Premier Oil were also in demand was Brent crude continued its rebound and was trading above $60 a a barrel for the first time in 2015.Glaxosmithkline's shares were given a boost by UBS which upgraded its rating for the pharmaceutical stock by two notches from 'sell' to 'buy', saying that the business is now at an "inflection point" after a tough few years. The bank hiked its target price for the stock from 1,250p to 1,700p,Utilities group Severn Trent declined after saying that while it is on track to hit expectations this financial year, operating costs are expected to rise due to the impact of inflation and quasi taxes.Rolls-Royce also fell despite the engine maker meeting forecasts with its 2014 results, as it said it expects profits to fall further this year as customers face "increased uncertainty" from weaker oil prices.Shire edged higher after a strong jump the previous session following its fourth-quarter results. The pharma group was also in focus on speculation it is preparing to make a bid for US peer Salix Pharmaceuticals, worth $9.2bn at current market prices.Market MoverstechMARK 3,126.19 +0.32%FTSE 100 6,869.16 +0.60%FTSE 250 16,894.80 +0.51%FTSE 100 - RisersTullow Oil (TLW) 403.20p +4.70%Glencore (GLEN) 288.30p +4.12%BHP Billiton (BLT) 1,554.00p +3.98%GlaxoSmithKline (GSK) 1,544.50p +3.97%Anglo American (AAL) 1,206.50p +3.52%Rio Tinto (RIO) 3,139.00p +3.27%Antofagasta (ANTO) 728.50p +3.26%BG Group (BG.) 962.80p +3.04%Weir Group (WEIR) 1,889.00p +2.66%Barclays (BARC) 258.75p +2.13%FTSE 100 - FallersBT Group (BT.A) 440.10p -2.20%United Utilities Group (UU.) 954.00p -1.95%easyJet (EZJ) 1,708.00p -1.95%InterContinental Hotels Group (IHG) 2,623.00p -1.58%SSE (SSE) 1,577.00p -1.44%ARM Holdings (ARM) 1,070.00p -1.38%Ashtead Group (AHT) 1,086.00p -1.27%National Grid (NG.) 883.50p -1.24%Severn Trent (SVT) 2,033.00p -1.17%Sage Group (SGE) 469.70p -1.05%FTSE 250 - RisersAfren (AFR) 8.26p +16.17%Vedanta Resources (VED) 523.50p +10.68%Premier Oil (PMO) 167.70p +5.54%RPS Group (RPS) 239.20p +5.42%Kaz Minerals (KAZ) 256.80p +4.26%Evraz (EVR) 194.30p +3.74%BlackRock World Mining Trust (BRWM) 331.60p +3.46%Atkins (WS) (ATK) 1,355.00p +3.04%Lonmin (LMI) 161.60p +2.93%Oxford Instruments (OXIG) 735.50p +2.87%FTSE 250 - FallersAO World (AO.) 285.90p -6.14%Supergroup (SGP) 1,022.00p -3.49%Bwin.party Digital Entertainment (BPTY) 99.05p -3.37%Acacia Mining (ACA) 273.40p -2.74%Hunting (HTG) 494.10p -1.77%Ocado Group (OCDO) 385.00p -1.53%Euromoney Institutional Investor (ERM) 985.00p -1.50%Go-Ahead Group (GOG) 2,422.00p -1.30%Rank Group (RNK) 184.70p -1.23%TalkTalk Telecom Group (TALK) 319.90p -1.17%
More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.